இப்செங் ஒன்றுபட்டது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Overcoming diagnostic challenges in rare diseases through innovative digital health partnerships
17th March 2021
ADVERTISEMENT FEATURE
 
This piece is written and sponsored by Ipsen UK
At Ipsen, we are committed to supporting patients with rare diseases throughout their disease journey – from diagnosis through to treatment follow-up. By nature of being rare conditions, many are challenging to diagnose; often, GPs are expected to spot symptoms of conditions that many never see in their entire careers. Around a quarter of people affected across Europe are thought to wait between five and 30 years for a correct diagnosis
1, and symptoms are often mistaken for other, less serious issues. In neuroendocrine cancers, for example, symptoms can include fatigue or feeling bloated and over half of patients are thought to be advised by their GP to simply come back if symptoms persist. COVID-19 has further exacerbated referral challenges, with a DATA-CAN report not ....

United Kingdom , Ipsen Pharmaceuticals , Ipsen Pharmaceutical Global Digital Health Partnerships , Ipsen United , United Kingdom Government , Rare Disease Framework , Data Privacy , ஒன்றுபட்டது கிஂக்டம் , இப்செங் மருந்துகள் , இப்செங் மருந்து உலகளாவிய டிஜிட்டல் ஆரோக்கியம் கூட்டாண்மை , இப்செங் ஒன்றுபட்டது , ஒன்றுபட்டது கிஂக்டம் அரசு , ரேர் நோய் கட்டமைப்பு , தகவல்கள் ப்ரைவஸீ ,